Moody's Investors Service has assigned an "Aa3" rating to the University of Chicago Medical Center's proposed $175 million of series 2016A and 2016B revenue bonds.
The rating assignment is based on a number of factors, including UCMC's growing operating cash flow, increasing market share and the benefits it enjoys as a controlled entity of the "Aa2"-rated University of Chicago.
The outlook is stable, reflecting Moody's Investors Service's expectation that UCMC will continue to produce improved cash flow margins and maintain its solid liquidity position.